SFL Regulatory Affairs & Scientific Communication

What SFL Regulatory Affairs & Scientific Communication does

SFL Regulatory Affairs & Scientific Communication (Solutions for Life Science) was a Basel, Switzerland-based regulatory and scientific consulting firm serving pharmaceutical, biotechnology, medical device, and rare disease developers across the product lifecycle. Its service portfolio spanned regulatory strategy and submissions, pharmacovigilance, market access and reimbursement, supply chain support for drugs/biologics/devices, healthcare compliance, and quality assurance — delivered on a professional services, quote-based engagement model typical of mid-tier regulatory consultancies. The firm was structured as a boutique, with primary targeting of pharma and biotech clients and secondary targeting of medical device/IVD companies; pricing was not publicly disclosed.

SFL has been acquired by and fully integrated into Veristat, LLC, a US-based private CRO. The SFL entity no longer operates independently; its Basel office now functions as Veristat's European headquarters. The integration extends the combined organization's offering from regulatory consulting into full-service clinical operations, biometrics, medical writing, and therapeutic-area solutions (oncology, neurology, infectious disease, cardiovascular, biologics including cell/gene therapy, rare disease/pediatric, decentralized trials, and natural history studies). Marketing is conducted through industry events, webinars, case studies, blog/library content, newsletters, and social channels (LinkedIn, Twitter/X, Facebook, YouTube), with all demand conversion routed through direct enterprise sales and an RFP intake flow. No AI/ML, API, SDK, or proprietary technology assets are disclosed; the moat rests on regulatory expertise, integrated cross-functional packaging, and the consulting talent base.

Name

SFL Regulatory Affairs & Scientific Communication

Legal name

Veristat, LLC

Website

https://sfl-services.com

Company type

Private

Founded year

2009

Operating status

Acquired

Headcount range

11–50 employees

Short description

SFL Regulatory Affairs & Scientific Communication was a Basel-based regulatory and scientific consulting firm for pharma, biotech, medical device, and rare disease developers; it has been acquired by and fully integrated into US-based CRO Veristat.

Ownership category

akta.pro rank

Product category

Regulatory Affairs Consulting

NAICS

Management Consulting Services (54161), Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH)

Keywords

• Regulatory affairs consulting
• Pharmacovigilance services
• Clinical development support
• Market access reimbursement
• Healthcare compliance advisory

Headquarters

HQ city

Basel

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Regulatory Consulting Services: Provides regulatory strategy, consulting, and submission services for clinical development programs and marketing applications throughout the product lifecycle.
2. Pharmacovigilance Services: Safety management services throughout the product lifecycle, including clinical trial safety, data monitoring committees, and medical monitoring.
3. Market Access and Reimbursement: Strategic consulting to secure early access and reimbursement for drugs and biologics.
4. Supply Chain Services: Expert services to establish and maintain seamless supply of commercial and investigational products for drugs, biologics, and medical devices.
5. Healthcare Compliance Services: Strategic expertise to ensure compliant relations and promotional materials for healthcare companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

SFL (now operating as Veristat) provides integrated consulting solutions for life sciences companies across the development and commercialization lifecycle. Core offerings include regulatory affairs strategy, pharmacovigilance, market access and reimbursement consulting, supply chain services, healthcare compliance advisory, and quality assurance/compliance services for pharmaceutical, biotechnology, and medical device clients.

Product overview

SFL Regulatory Affairs & Scientific Communication (now part of Veristat) offers an integrated suite of clinical development and regulatory affairs consulting services. The portfolio spans core regulatory services (Regulatory Affairs, Pharmacovigilance, Market Access/Reimbursement, Supply Chain, Healthcare Compliance, and Quality Assurance & Compliance), supported by strategic service modules (Strategic Consulting, Clinical Operations, Medical Affairs, Medical Writing, Biometrics, Regulatory Writing, and Resourcing/FSP). Solutions are organized around key therapeutic approaches including Biologics (Cell and Gene Therapies, Vaccine Trials), Rare Diseases (including Pediatric), Decentralized Trials, Rescue Trials, and Natural History Trials. The company provides integrated consulting solutions across the entire development and commercialization lifecycle, from program design through full-service clinical trial execution and therapy commercialization.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Affairs Regulatory expertise and strategy throughout all phases of clinical development into commercialization, including regulatory consulting for program and trial design, marketing applications, CMC, agency meetings, and regulatory publishing.
• Pharmacovigilance Safety management throughout the product lifecycle, including clinical trial safety, data monitoring committees, and medical monitoring.
• Market Access and Reimbursement Strategic consulting to apply knowledge and insights to secure early access and reimbursement for drugs and biologics.
• Supply Chain Services Expert services to establish and maintain seamless supply of commercial and investigational products for drugs, biologics, and medical devices.
• Healthcare Compliance Strategic expertise to ensure compliant relations and promotional materials for healthcare products.
• Quality Assurance and Compliance Quality compliance services from quality management systems (QMS) establishment to quality oversight of marketed products.
• Biologics Solutions Full-service CRO solutions for biologics development, including cell and gene therapies and vaccine trials.
• Rare Diseases Solutions Specialized solutions for rare disease clinical trials, including pediatric clinical trials.
• Clinical Operations Full-service clinical trial execution including project management, monitoring and site management, patient recruitment, and patient retention and site engagement.
• Biometrics Services Comprehensive biometrics services including data management, biostatistics, statistical programming, and standards implementation.
• Strategic Resourcing/FSP Flexible staffing solutions and functional service provider (FSP) resourcing for clinical development programs.
• Decentralized Trials Decentralized clinical trial solutions enabling remote participation and distributed data collection.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• VeristatflagshipStrategic or Co-development PartnerSFL has been acquired by and integrated into Veristat, creating a combined organization with expanded capabilities in clinical development, regulatory affairs, and market access. The integration enables SFL to better serve clients' clinical development and regulatory affairs needs across the product development lifecycle, from program design to full-service clinical trial execution and therapy commercialization.

Scale indicators1 record

Recent moves4 records

Expansion highlights5 records

Market position

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xtwitter.com/VeristatCRO
• YouTubeyoutube.com/@veristat
• Facebookfacebook.com/VeristatCRO
• LinkedInlinkedin.com/company/veristat-llc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SFL Regulatory Affairs & Scientific Communication